Low clinical sensitivity and unexpectedly high incidence for neuropathologically diagnosed progressive supranuclear palsy-Reference-Cited by-同舟云学术

Low clinical sensitivity and unexpectedly high incidence for neuropathologically diagnosed progressive supranuclear palsy

Published:2023-04-20 Issue:5 Volume:82 Page:438-451
ISSN:0022-3069
Container-title:Journal of Neuropathology & Experimental Neurology
language:en
Short-container-title:

Author:

Driver-Dunckley Erika D,Zhang Nan,Serrano Geidy E,Dunckley Nathaniel A,Sue Lucia I,Shill Holly A,Mehta Shyamal H,Belden Christine,Tremblay Cecilia,Atri Alireza,Adler Charles H,Beach Thomas G

Funder

AZSAND

National Institute of Neurological Disorders and Stroke

National Brain and Tissue Resource for Parkinson's Disease and Related Disorders

National Institute on Aging

Arizona Alzheimer's Disease Core Center

Arizona Department of Health Services

Arizona Alzheimer’s Research Center

Arizona Biomedical Research Commission

Arizona Parkinson's Disease Consortium

Michael J. Fox Foundation for Parkinson’s Research

Mayo Clinic Foundation

Publisher

Oxford University Press (OUP)

Subject

Cellular and Molecular Neuroscience,Neurology (clinical),Neurology,General Medicine,Pathology and Forensic Medicine

Link

https://academic.oup.com/jnen/article-pdf/82/5/438/49952607/nlad025.pdf

Reference65 articles.

1. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia;Steele;Arch Neurol,1964

2. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy);Hauw;Neurology,1994

3. Validity and reliability of the preliminary NINS neuropathologic criteria for progressive supranuclear palsy and related disorders;Litvan;J Neuropathol Exp Neurol,1996

4. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP International Workshop;Litvan;Neurology,1996

5. Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank;Josephs;Mov Disord,2003

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CSF α-Synuclein Seed Amplification Assay in Patients With Atypical Parkinsonian Disorders;Neurology;2024-09-24

2. Limitations of the α-Synuclein Seed Amplification Assay in Clinical Practice;JAMA Neurology;2024-09-01

3. Ethnic background and distribution of clinical phenotypes in patients with probable progressive supranuclear palsy;Parkinsonism & Related Disorders;2024-06

4. Conjugal Synucleinopathies: A Clinicopathologic Study;Movement Disorders;2024-04-10

5. Flanagan’s condensed protocol for neurodegenerative diseases. Implementation in a clinical autopsy setting with partial supervision of a neuropathologist;Virchows Archiv;2024-03-12